Loading organizations...
Loading organizations...
Developing proprietary hydrogels for tissue regeneration.
Regentis Biomaterials has raised $25.0M across 2 funding rounds.
Regentis Biomaterials has raised $25.0M in total across 2 funding rounds.
Regentis Biomaterials has raised $25.0M in total across 2 funding rounds.
Regentis Biomaterials's investors include Haisco Pharmaceutical Group, Generali, Medica Venture Partners, SCP Vitalife Partners, Technion Innovation Opportunities Fund, Technion Research and Development Foundation, Crossroad Fund, Royal DSM, Technion.
Regentis Biomaterials has raised $25.0M across 2 funding rounds. Most recently, it raised $15.0M Series D in February 2016.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 11, 2016 | $15.0M Series D | Haisco Pharmaceutical Group | Generali, Medica Venture Partners, SCP Vitalife Partners, Technion Innovation Opportunities Fund, Technion Research and Development Foundation |
| May 14, 2012 | $10.0M Series C | Crossroad Fund, Medica Venture Partners, Royal DSM, SCP Vitalife Partners, Technion |